HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor.

Abstract
The renal tubular Fanconi syndrome developed in five patients with Wilms tumor after treatment with ifosfamide, a derivative of cyclophosphamide. Glomerular filtration rates were severely decreased. Renal function was investigated because of the development of rickets. All patients had undergone reduction of renal mass by nephrectomy. None had preexisting renal tubular injury. The syndrome developed at cumulative doses of ifosfamide of 39 to 99 gm/m2. Low serum bicarbonate and phosphate concentrations with glucosuria, aminoaciduria, and hypochloremic metabolic acidosis were the manifestations of the Fanconi syndrome. Bicarbonate and phosphate replacement resulted in bone healing, but recovery of tubular and glomerular function did not occur. Monitoring of these laboratory values during ifosfamide therapy could allow earlier replacement therapy to prevent severe bone disease.
AuthorsC D Burk, I Restaino, B S Kaplan, A T Meadows
JournalThe Journal of pediatrics (J Pediatr) Vol. 117 Issue 2 Pt 1 Pg. 331-5 (Aug 1990) ISSN: 0022-3476 [Print] United States
PMID2166154 (Publication Type: Journal Article)
Chemical References
  • Ifosfamide
Topics
  • Child
  • Child, Preschool
  • Chronic Kidney Disease-Mineral and Bone Disorder (chemically induced)
  • Fanconi Syndrome (chemically induced)
  • Female
  • Glomerular Filtration Rate (drug effects)
  • Humans
  • Ifosfamide (adverse effects, therapeutic use)
  • Infant
  • Kidney Neoplasms (drug therapy)
  • Male
  • Wilms Tumor (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: